CLIA waiver will be a major milestone. Even Atomo Diagnostics - who supply the cartridge and who were largely measured in their expectations for US launch of FebriDX - noted this in a recent email.
Way way way back when it was all but assumed that LDX would get the FDA approval, Atomo significantly ramped up supply to LDX. Obviously, much has changed since then.
Here is hoping that both companies have a prosperous New Year!
LDX Price at posting:
6.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.